Biodesix

(NASDAQ) BDSX

Current Price$15.63

Market Cap$159.21M

Since IPO (2020)-94%

5 Year-94%

1 Year+119%

1 Month+20%

Biodesix Financials at a Glance

Market Cap

$159.21M

Revenue (TTM)

$96.10M

Net Income (TTM)

$31.96M

EPS (TTM)

$-4.03

P/E Ratio

-3.91

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$15.63

Volume

835

Open

$15.80

Price

$15.63

Volume

835

Open

$15.80

Previous Close

$15.63

Daily Range

$15.40 - $16.10

52-Week Range

$3.44 - $20.21

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$15.63

Volume

835

Open

$15.80

Previous Close

$15.63

Daily Range

$15.40 - $16.10

52-Week Range

$3.44 - $20.21

BDSX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biodesix

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

334

CEO

Scott Hutton

Website

www.biodesix.com

Headquarters

Boulder, CO 80301, US

BDSX Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

-26%

Net Income Margin

-33%

Return on Equity

-317%

Return on Capital

-31%

Return on Assets

-34%

Earnings Yield

-25.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$159.21M

Shares Outstanding

10.11M

Volume

835

Avg. Volume

107.72K

Financials (TTM)

Gross Profit

$71.78M

Operating Income

$27.77M

EBITDA

$21.95M

Operating Cash Flow

$23.27M

Capital Expenditure

$403.00K

Free Cash Flow

$23.67M

Cash & ST Invst.

$18.99M

Total Debt

$72.85M

Biodesix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$25.55M

+42.3%

Gross Profit

$21.35M

+49.8%

Gross Margin

83.55%

N/A

Market Cap

$159.21M

N/A

Market Cap/Employee

$583.19K

N/A

Employees

273

N/A

Net Income

$7.79M

+29.8%

EBITDA

$4.40M

+45.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$46.04M

-3.0%

Accounts Receivable

$9.50M

+24.4%

Inventory

$0.00

N/A

Long Term Debt

$70.16M

+14.7%

Short Term Debt

$1.45M

+30.8%

Return on Assets

-33.77%

N/A

Return on Invested Capital

-31.11%

N/A

Free Cash Flow

$10.31M

-18.0%

Operating Cash Flow

$10.17M

-18.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MRSNMersana Therapeutics, Inc.

MRSNMersana Therapeutics, Inc.$29.08+0.00%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$1.10-15.38%

OKUROnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.$3.39-1.45%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$7.73+0.00%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$6.47+4.19%

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.39+2.96%

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.$0.81-7.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.96-0.05%

NOKNokia

NOKNokia$13.17-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.96-0.03%

POETPoet Technologies

POETPoet Technologies$13.73-0.01%

WOKWork Medical Technology Group Ltd

WOKWork Medical Technology Group Ltd$6.66+0.70%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.31+0.03%

IRENIren

IRENIren$56.56+0.03%

Questions About BDSX

What is the current price of Biodesix?

Biodesix is trading at $15.63 per share.

What is the 52-week range for Biodesix?

Over the past 52 weeks, Biodesix has traded between $3.44 and $20.21.

How much debt does Biodesix have?

As of the most recent reporting period, Biodesix reported total debt of $71.61M.

How much cash does Biodesix have on hand?

Biodesix reported $25.67M in cash and cash equivalents in its most recent financial results.

What is Biodesix’s dividend yield?

Biodesix does not currently have a dividend yield.

Biodesix

Biodesix Financials at a Glance

BDSX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biodesix

BDSX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biodesix Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BDSX

What is the current price of Biodesix?

What is the 52-week range for Biodesix?

How much debt does Biodesix have?

How much cash does Biodesix have on hand?

What is Biodesix’s dividend yield?

Premium Investing Services